prvi bosansko-hercegovački i drugi jadranski kongres ...
prvi bosansko-hercegovački i drugi jadranski kongres ...
prvi bosansko-hercegovački i drugi jadranski kongres ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
P 02<br />
Economic evaluation of decreasing persistant hypertension with renal<br />
denervation device cutting costs of hypertension commorbidities in<br />
upcoming Croatian practice<br />
Vanesa Benković 1 , Ranko Stevanović 1 , Ana Ivičević 1 , Marko Matulović 2 ,<br />
Bojan Jelaković 3<br />
1 Croatian Society for Pharmacoeconomics and<br />
Health Economics Zagreb, Croatia<br />
2 Medtronic Zagreb, Croatia<br />
3 Department for nephrology and arterial<br />
hypertension, Clinical Hospital Centre Zagreb,<br />
Croatia<br />
Goal: to assess cost saving of decrease in persistant<br />
hypertension using renal denervation, a<br />
novel a catheter-based procedure<br />
Materials and Methods: using RCT data on decreasing<br />
commorbidities of hypertension and<br />
Framingham risk score a model is set to establish<br />
and structure cost in cardiovascular, cerebrovascular<br />
and renal commorbidities. Cost savings in<br />
commorbidities is assessed in Croatian setting<br />
using current prices and DRG tariffs. Epideimology<br />
data is taken from existing research such as<br />
registries and Croatian Health Survey.<br />
Results and Conclusion: Hypertension is a<br />
major risk factor for stroke, ischemic heart disease,<br />
heart failure, end stage renal disease and<br />
peripheral arterial disease. Renal denervation<br />
with the Symplicity Catheter System is a new<br />
catheter-based procedure for treatment-resistant<br />
48 Proofreading and translations are in the explicit responsibility of the authors.<br />
hypertension. Treatment-resistant hypertensive<br />
patients currently have no additional treatment<br />
options; they represent a significant unmet clinical<br />
need. Using one time renal denervation may<br />
significantly decrease systolic blood presure<br />
(SBP) - up to 32 mmHG SBP in six months, with<br />
sustainable effect. Decreasing the SBP is associated<br />
with decrease in incidence of ischaemic<br />
heart disease, renal failure, cerebrovascular insult<br />
and correlated mortality. As they all negatively<br />
impact quality of life they also increase the<br />
economic burden of the disease. The novel renal<br />
denervation procedure brings excellent options<br />
for unmet need in persistant hypertension and<br />
decreases cost in hospitalizations, drugs and rehabilitation<br />
from the budget holder and the hospital<br />
perspective.
Change language